Description
Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from the thymus gland, where it is endogenously produced. It functions as a potent modulator of the immune system, primarily by enhancing T-cell maturation and function. The peptide’s mechanism of action involves stimulating the production of cytokines, such as interleukin-2 and interferon-gamma, which are crucial for orchestrating an effective immune response against viral infections and malignancies. Research has extensively focused on its role in augmenting the immune response in various clinical contexts. Key areas of investigation include its application as an adjunct therapy in the treatment of chronic hepatitis B and C, and its potential to restore immune function in immunocompromised individuals. Further studies are exploring its efficacy in oncology and as an immune enhancer for vaccines. This product is intended for research purposes only and is not for human consumption.
CAS: 62304-98-7
PubChem CID: 16130571
Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight: 3108.3 g/mol
Amino Acid Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn (28 aa, N-acetylated)
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture


